Apex Wound Care

Healthcare · Southeast US · Active Mandate

Deal Size

$55M

Revenue

$42M

Growth

22%

EBITDA Margin

28%

Ready Now

Sellability Score

88/100

Asset quality, growth, margins

Buyer Readiness

76/100

Buyer universe engagement

Momentum Score

82/100

Process activity and recency

Intelligence Summary

High-quality healthcare asset with strong margins and recurring revenue. Multiple PE buyers actively engaged. Process momentum is strong — accelerate outreach now.

Owner Intelligence Profile

Robert Haines

Founder & CEO · Age 61 · 24 years in business

Succession Risk

High

Communication Style

Relational, story-driven. Prefers in-person or phone over email. Uses healthcare mission language. Responds well to peer references.

Motivation Profile

Legacy + Patient Impact. Built this to improve home care for underserved Medicare patients. Will not sell to a buyer who will cut services or rebrand.

Succession Intelligence

No named successor. COO departed 8 months ago. Founder has reduced conference appearances. Daughter enrolled in law school — not entering the business.

Live Signals

LinkedIn: last 3 posts focus on "legacy" and "what we built together"

Conference speaking: shifted from growth topics to workforce and mission

New home purchase recorded in public records — 8 months ago

Board composition: added independent director with exit experience last year

Situational Triggers

CMS reimbursement rate change announced Q3 — creates planning uncertainty

Regional competitor (SunBridge Home Health) sold to PE in September

Key clinical director departed 6 months ago — operational stress signal

Founder turned 61 last month — actuarially significant for succession planning

Trust-Building Tactics

Reference a specific patient outcome story from their press coverage

Name-drop a respected operator in home health who you have a relationship with

Lead with what happens to the team and patients post-close — not valuation

Share a relevant CMS regulatory insight before asking for anything

Avoid

—

Avoid mentioning cost-cutting or margin improvement in early calls

—

Do not lead with EBITDA multiples — frame value as enterprise legacy

—

Avoid aggressive timelines — this founder moves on trust, not urgency

Recommended First Outreach Script

"Robert — I've followed Apex for a few years and what you've built in wound care is genuinely rare. The clinical outcomes data you published last year caught my attention — that's not something you see from a business that's just chasing reimbursement. I work with a small group of healthcare PE firms who are specifically looking for founder-led platforms with your profile. I'm not calling to pitch a transaction. I'm calling because I think it's worth 20 minutes to understand where you want to take this in the next 5 years, and whether there's a smarter way to get there. Would Thursday afternoon work?"

Recommended Follow-Up Script

"Robert — following up on our conversation. I pulled together a short overview of three comparable home health transactions from the past 18 months — the multiples may surprise you, and more importantly, two of those founders are still running their businesses day-to-day. Happy to share if useful. No agenda other than making sure you have the full picture when you're ready to think about this."

Historical Pattern Match

Pattern Match

Resembles 3 closed deals

Est. Time to Close

4-6 months

Key Risk

Founder may pursue recapitalization inst...

Profile matches Southeast healthcare services deals closed 2021-2023. Average time from first contact to LOI: 4.8 months. Common pattern: warm intro via industry peer, followed by 2-3 value-add touchpoints before process discussion.

Recommended Buyers

Linden CapitalPE

Pure-play healthcare PE, wound care fits thesis exactly

Welsh CarsonPE

Healthcare and services focus, check size fits

Gryphon InvestorsPE

Gryphon ops focus ideal for services rollup

Riverside CompanyPE

Riverside active in lower-middle healthcare

Recent Interactions

Welsh Carsonmanagement meeting2024-11-12

Welsh Carson management meeting. Strong conviction.

Gryphon Investorsintro call2024-11-10

Strong interest, requested mgmt time.

Welsh Carsonnda signed2024-11-08

NDA executed, CIM sent.

McKesson Corpintro call2024-11-03

McKesson exploring wound care services angle.

Linden Capitalmanagement meeting2024-11-01

Met with CEO, very positive. Proceeding to IOI.

Sentinel Capitalintro call2024-10-30

Initial interest, awaiting follow-up.

Riverside Companynda signed2024-10-22

In process, reviewing CIM.

Varsity Healthcare Partnersintro call2024-10-15

Varsity initial interest in wound care angle.